20q13.33 microdeletion syndrome

ORPHA: 261311

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with 20q13.33 microdeletion syndrome, sourced from HPO and Orphanet clinical annotations.

Delayed speech and language developmentIntellectual disabilityHypotoniaGrowth delaySmall for gestational ageAbnormal limb bone morphologyDilation of Virchow-Robin spacesNeurodevelopmental delayPosteriorly rotated earsDownslanted palpebral fissuresUpslanted palpebral fissureSeizureFailure to thrive in infancyShort lower limbsHypospadiasThin vermilion borderEpicanthusFacial hypotoniaHypertelorismSmooth philtrumTriangular faceNarrow foreheadBulbous noseNarrow noseProptosisAutistic behaviorSacral dimpleTapered fingerOligohydramniosAtrial septal defectAbnormal cardiac ventricle morphologyTalipes equinovarusPes planusHallux valgusHypoplasia of the corpus callosumDelayed CNS myelinationHighly arched eyebrowHematocheziaHip dislocationAplasia/Hypoplasia of the nipplesProminent crus of helixHypoplastic aortic archDecreased scrotal rugation

Classification & Codes

Orphanet Code

ORPHA:261311
20q13.33 microdeletion syndrome
OrphanetORPHA:261311
Treatments0 drug(s)
Symptoms on record43 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
20q13.33 microdeletion syndrome | OrphanDrug